M Hadjiyannakis

The Role of p53, MDM2 and c-erb B-2 Oncoproteins, Epidermal Growth Factor Receptor and Proliferation Markers in the Prognosis of Urinary Bladder Cancer

Penelope Korkolopoulou, Panayota Christodoulou, Panayotis Kapralos et al. · Pathology - Research and Practice · 1997 · 104 citations

Medicine, Oncology, Urology +13

MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor

P. Korkolopoulou, P. Christodoulou, Konstantinos Kouzelis et al. · British Journal of Cancer · 1997 · 99 citations · Full text

Medicine, Oncology, Pathology +15

Topographical immunohistochemical expression of bcl-2 protein in human liver lesions.

A. Skopelitou, M Hadjiyannakis, Vana Alexopoulou et al. · PubMed · 1996 · 28 citations

Medicine, Oncology, Pathology +17

p53 and c-jun Expression in Urinary Bladder Transitional Cell Carcinoma: Correlation with Proliferating Cell Nuclear Antigen (PCNA) Histological Grade and Clinical Stage

A. Skopelitou, M Hadjiyannakis, Demetrios Dimopoulos et al. · European Urology · 1997 · 26 citations

Medicine, Oncology, Urology +12

Expression of C-myc p62 oncoprotein in multiple myeloma: an immunohistochemical study of 180 cases.

A. Skopelitou, M Hadjiyannakis, A Tsenga et al. · PubMed · 1993 · 21 citations

Medicine, Molecular Biology, Oncology +17